Anne S. Dejean

Anne S. Dejean

Auto-generated profile, based on publicly available information

Anne S. Dejean

UMR Inserm, U1043, Toulouse, France

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2009 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
YKYann M Kerdiles
Yann M Kerdiles
DBDaniel R Beisner
Daniel R Beisner
RTRoberto Tinoco
Roberto Tinoco
ADAnne S Dejean
Anne S Dejean
DCDiego H Castrillon
Diego H Castrillon
SHStephen M Hedrick
Stephen M Hedrick

12 April 2009 in Nature Immunology
Verified
Journal Article
Open access
PDF file
ADAnne S Dejean
Anne S Dejean
DBDaniel R Beisner
Daniel R Beisner
ICIrene L Ch'EN
Irene L Ch'EN
YKYann M Kerdiles
Yann M Kerdiles
ABAnna Babour
Anna Babour
SHStephen M Hedrick
Stephen M Hedrick
Foxo transcription factors influence a wide variety of cellular responses. Hedrick and colleagues show that dendritic cells express Foxo3 to suppress the production of interleukin 6 and prevent excessive accumulation of antigen-specific T cells. Foxo transcription factors regulate cell cycle progression, cell survival and DNA-repair pathways. Here we demonstrate that deficiency in Foxo3 resulted in greater expansion of T cell populations after viral infection. This exaggerated expansion was not T cell intrinsic. Instead, it was caused by the enhanced capacity of Foxo3-deficient dendritic cells to sustain T cell viability by producing more interleukin 6. Stimulation of dendritic cells mediated by the coinhibitory molecule CTLA-4 induced nuclear localization of Foxo3, which in turn inhibited the production of interleukin 6 and tumor necrosis factor. Thus, Foxo3 acts to constrain the production of key inflammatory cytokines by dendritic cells and to control T cell survival.

15 November 2004 in Blood
Verified
Journal Article
Closed access
EXEmmanuel Xystrakis
Emmanuel Xystrakis
ADAnne S. Dejean
Anne S. Dejean
IBIsabelle Bernard
Isabelle Bernard
PDPhilippe Druet
Philippe Druet
RLRoland Liblau
Roland Liblau
Abdelhadi SaoudiAbdelhadi Saoudi
Abdelhadi Saoudi
The immune system contains natural regulatory T cells that control the magnitude of the immune response during physiologic and pathologic conditions. Although this suppressive function was historically attributed to CD8 T cells, most recent reports have focused on natural regulatory CD4 T cells. In the present study, we describe a new subset of natural CD8 regulatory T cells in normal healthy animals. This subset expresses low levels of CD45RC at its surface (CD45RClow); produces mainly interleukin-4 (IL-4), IL-10, and IL-13 cytokines upon in vitro stimulation; expresses Foxp3 and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4); and is not cytotoxic against allogeneic targets. This subset suppresses the proliferation and differentiation of autologous CD4 T cells into type-1 cytokines producing T cells after stimulation with allogeneic accessory cells. We also provide evidence that this regulatory subset mediates its suppression by cell-to-cell contact and not through secretion of suppressive cytokines. Finally, the regulatory activity of CD8 CD45RClow cells is also demonstrated in vivo in a rat model of CD4-dependent graft-versus-host disease. Collectively, these data demonstrate for the first time that freshly isolated rat CD8 CD45RClow T cells contain T cells with regulatory properties, a result that enlarges the general picture of T-cell-mediated regulation. (Blood. 2004;104:3294-3301)

20 September 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
STSelma Tuzlak
Selma Tuzlak
ADAnne S. Dejean
Anne S. Dejean
MIMatteo Iannacone
Matteo Iannacone
FQFrancisco J. Quintana
Francisco J. Quintana
AWAri Waisman
Ari Waisman
BBBurkhard Becher
Burkhard Becher

1 October 2020 in Immunity
Verified
Journal Article
Closed access
MWMarianne Weulersse
Marianne Weulersse
AAAssia Asrir
Assia Asrir
APAndrea C. Pichler
Andrea C. Pichler
LLLea Lemaitre
Lea Lemaitre
MBMatthias Braun
Matthias Braun
LMLudovic Martinet
Ludovic Martinet

14 September 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
JZJiang Zhang
Jiang Zhang
SGStéphanie Le Gras
Stéphanie Le Gras
KPKevin Pouxvielh
Kevin Pouxvielh
FFFabrice Faure
Fabrice Faure
LFLucie Fallone
Lucie Fallone
TWThierry Walzer
Thierry Walzer
EOMES and T-BET are related T-box transcription factors that control natural killer (NK) cell development. Here we demonstrate that EOMES and T-BET regulate largely distinct gene sets during this process. EOMES is dominantly expressed in immature NK cells and drives early lineage specification by inducing hallmark receptors and functions. By contrast, T-BET is dominant in mature NK cells, where it induces responsiveness to IL-12 and represses the cell cycle, likely through transcriptional repressors. Regardless, many genes with distinct functions are co-regulated by the two transcription factors. By generating two gene-modified mice facilitating chromatin immunoprecipitation of endogenous EOMES and T-BET, we show a strong overlap in their DNA binding targets, as well as extensive epigenetic changes during NK cell differentiation. Our data thus suggest that EOMES and T-BET may distinctly govern, via differential expression and co-factors recruitment, NK cell maturation by inserting partially overlapping epigenetic regulations.